Acadia Pharmaceuticals (ACAD) Prepaid Assets (2010 - 2026)
Acadia Pharmaceuticals' (ACAD) quarterly Prepaid Assets came in at $64.6 million in Q1 2026, up 22.57% year-on-year from $52.7 million in Q1 2025, and up 8.52% quarter-over-quarter from $59.5 million in Q4 2025.
Acadia Pharmaceuticals (ACAD) Prepaid Assets (2010 - 2026) Analysis & Trends
Acadia Pharmaceuticals' Prepaid Assets history runs 17 years deep, the most recent figure standing at $64.6 million for Q1 2026.
- On a quarterly basis, Prepaid Assets rose 22.57% year-over-year to $64.6 million in Q1 2026; TTM through Mar 2026 was $64.6 million, a 22.57% increase from a year earlier, with the FY2025 full-year figure at $59.5 million, up 6.91% from the prior year.
- Prepaid Assets grew to $64.6 million in Q1 2026 per ACAD's latest filing, from $59.5 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $64.6 million in Q1 2026 and bottomed at $21.0 million in Q2 2022.
- The 5-year median for Prepaid Assets is $42.8 million (2024), against an average of $41.3 million.
- Across the five-year window, Prepaid Assets fell 20.05% in 2022 and surged 92.74% in 2024, its largest moves.
- Year by year, Prepaid Assets stood at $21.4 million in 2022, then surged by 82.69% to $39.1 million in 2023, then jumped by 42.44% to $55.7 million in 2024, then advanced by 6.91% to $59.5 million in 2025, then gained by 8.52% to $64.6 million in 2026.
- Per Business Quant, the three latest ACAD Prepaid Assets figures stand at $64.6 million (Q1 2026), $59.5 million (Q4 2025), and $60.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Acadia Pharmaceuticals | 4.23 Bn | 3.38 Bn | 243.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 64.60 Mn |
| Dec 31, 2025 | 59.53 Mn |
| Sep 30, 2025 | 60.87 Mn |
| Jun 30, 2025 | 52.75 Mn |
| Mar 31, 2025 | 52.70 Mn |
| Dec 31, 2024 | 55.68 Mn |
| Sep 30, 2024 | 51.55 Mn |
| Jun 30, 2024 | 46.06 Mn |
| Mar 31, 2024 | 42.76 Mn |
| Dec 31, 2023 | 39.09 Mn |
| Sep 30, 2023 | 37.95 Mn |
| Jun 30, 2023 | 23.90 Mn |
| Mar 31, 2023 | 23.63 Mn |
| Dec 31, 2022 | 21.40 Mn |
| Sep 30, 2022 | 22.99 Mn |
| Jun 30, 2022 | 20.95 Mn |
| Mar 31, 2022 | 25.76 Mn |
| Dec 31, 2021 | 23.89 Mn |
| Sep 30, 2021 | 24.62 Mn |
| Jun 30, 2021 | 26.21 Mn |